Dopamine‐loaded blood exosomes targeted to brain for better treatment of Parkinson's disease
暂无分享,去创建一个
Ling Zhang | Yao Fu | Luyi Huang | Luyao Wang | Shanshan He | Zhirong Zhang | Ling Zhang | Yao Fu | Zhirong Zhang | Mengke Qu | Qing Lin | Yu Fu | Shengyong Yang | Xun Sun | Luyi Huang | Lu-yao Wang | Mengke Qu | Qing Lin | Yu Fu | Xun Sun | Shanshan He | S. Yang
[1] Ikuko Miyazaki,et al. Dopamine- or L-DOPA-induced neurotoxicity: The role of dopamine quinone formation and tyrosinase in a model of Parkinson’s disease , 2009, Neurotoxicity Research.
[2] J. Slot,et al. Proteomic and Biochemical Analyses of Human B Cell-derived Exosomes , 2003, The Journal of Biological Chemistry.
[3] G. Höglinger,et al. Dopamine and adult neurogenesis , 2007, Journal of neurochemistry.
[4] Meg Duroux,et al. A comprehensive overview of exosomes as drug delivery vehicles - endogenous nanocarriers for targeted cancer therapy. , 2014, Biochimica et biophysica acta.
[5] Jung-Ah Cho,et al. Exosomes: A new delivery system for tumor antigens in cancer immunotherapy , 2005, International journal of cancer.
[6] Myung Soo Kim,et al. Development of exosome-encapsulated paclitaxel to overcome MDR in cancer cells. , 2016, Nanomedicine : nanotechnology, biology, and medicine.
[7] Hongzhe Sun,et al. Targeted Drug Delivery via the Transferrin Receptor-Mediated Endocytosis Pathway , 2002, Pharmacological Reviews.
[8] Sandra L. Schmid,et al. Regulated portals of entry into the cell , 2003, Nature.
[9] F F SAVERIO,et al. [Cerebral circulation]. , 1954, Omnia therapeutica. Supplemento.
[10] Rui-sheng Li,et al. Rhein protects against acetaminophen-induced hepatic and renal toxicity. , 2011, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[11] U. Knaus,et al. Cellular ROS imaging with hydro-Cy3 dye is strongly influenced by mitochondrial membrane potential. , 2017, Biochimica et biophysica acta. General subjects.
[12] Alan C. Evans,et al. Regional striatal DOPA transport and decarboxylase activity in Parkinson's disease. , 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[13] Current treatments in Parkinson's including the proposal of an innovative dopamine microimplant , 2016 .
[14] P. Schwartz,et al. Pharmacokinetics of dopamine in infants and children. , 1991 .
[15] Martin Fussenegger,et al. Designer exosomes produced by implanted cells intracerebrally deliver therapeutic cargo for Parkinson’s disease treatment , 2018, Nature Communications.
[16] S. Everse,et al. How the binding of human transferrin primes the transferrin receptor potentiating iron release at endosomal pH , 2011, Proceedings of the National Academy of Sciences.
[17] M. Wood,et al. Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes , 2011, Nature Biotechnology.
[18] M. Bruguera. Practical guidelines for examination of adults with asymptomatic hypertransaminasaemia. , 2017 .
[19] Jian Song,et al. A doxorubicin delivery platform using engineered natural membrane vesicle exosomes for targeted tumor therapy. , 2014, Biomaterials.
[20] Xin-guo Jiang,et al. Study and evaluation of mechanisms of dual targeting drug delivery system with tumor microenvironment assays compared with normal assays. , 2014, Acta biomaterialia.
[21] B. Pan,et al. Fate of the transferrin receptor during maturation of sheep reticulocytes in vitro: Selective externalization of the receptor , 1983, Cell.
[22] J. Brotchie,et al. The Pharmacology of l-DOPA-Induced Dyskinesia in Parkinson’s Disease , 2013, Pharmacological Reviews.
[23] A. Moustafa,et al. Dose-dependent neuroprotective effect of caffeine on a rotenone-induced rat model of parkinsonism: A histological study , 2016, Neuroscience Letters.
[24] Young Jik Kwon,et al. Good things come in small packages: Overcoming challenges to harness extracellular vesicles for therapeutic delivery. , 2016, Journal of controlled release : official journal of the Controlled Release Society.
[25] J. Connor,et al. Receptor‐mediated transcytosis of transferrin across the blood‐brain barrier , 1987, Journal of neuroscience research.
[26] T. Ochiya,et al. Systemically injected exosomes targeted to EGFR deliver antitumor microRNA to breast cancer cells. , 2013, Molecular therapy : the journal of the American Society of Gene Therapy.
[27] Dongmei Sun,et al. Treatment of brain inflammatory diseases by delivering exosome encapsulated anti-inflammatory drugs from the nasal region to the brain. , 2011, Molecular therapy : the journal of the American Society of Gene Therapy.
[28] S. Bentley,et al. Stability of hematologic parameters in healthy subjects. Intraindividual versus interindividual variation. , 1988, American journal of clinical pathology.
[29] Gema Moreno-Bueno,et al. Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET , 2012, Nature Medicine.
[30] Xin Hou,et al. Blood Exosomes Endowed with Magnetic and Targeting Properties for Cancer Therapy. , 2016, ACS nano.
[31] T. Dawson,et al. Molecular Pathways of Neurodegeneration in Parkinson's Disease , 2003, Science.
[32] J. Lötvall,et al. Exosomes purified from a single cell type have diverse morphology , 2016, bioRxiv.
[33] Stuart K Williams,et al. Endocytosis and exocytosis of protein in capillary endothelium , 1984, Journal of cellular physiology.
[34] C. Harding,et al. Exosomes: Looking back three decades and into the future , 2013, The Journal of cell biology.
[35] Anders Björklund,et al. Characterisation of behavioural and neurodegenerative changes induced by intranigral 6‐hydroxydopamine lesions in a mouse model of Parkinson’s disease , 2010, The European journal of neuroscience.
[36] J. A. Blom. Monitoring of respiration and circulation , 2003 .
[37] J. Philippot,et al. Asymmetric distribution of phospholipids in the membrane of vesicles released during in vitro maturation of guinea pig reticulocytes: Evidence precluding a role for “aminophospholipid translocase” , 1989, Journal of cellular physiology.
[38] Dongmei Sun,et al. A novel nanoparticle drug delivery system: the anti-inflammatory activity of curcumin is enhanced when encapsulated in exosomes. , 2010, Molecular therapy : the journal of the American Society of Gene Therapy.
[39] S. Chalon,et al. Drug Delivery Systems for Imaging and Therapy of Parkinson's Disease , 2016, Current neuropharmacology.
[40] Xun Sun,et al. Brain-specific delivery of dopamine mediated by n,n-dimethyl amino group for the treatment of Parkinson's disease. , 2014, Molecular pharmaceutics.
[41] Lionel Blanc,et al. Exosome release by reticulocytes--an integral part of the red blood cell differentiation system. , 2005, Blood cells, molecules & diseases.
[42] Á. Kittel,et al. A new blood–brain barrier model using primary rat brain endothelial cells, pericytes and astrocytes , 2009, Neurochemistry International.
[43] I. Emelin,et al. Creatine kinase in regulation of heart function and metabolism. I. Further evidence for compartmentation of adenine nucleotides in cardiac myofibrillar and sarcolemmal coupled ATPase-creatine kinase systems. , 1984, Biochimica et biophysica acta.